Otros idiomas Clinuvel Pharmaceuticals Limited

Acciones

CUV

AU000000CUV3

Mercado cerrado - Australian S.E. Otros sitios de cotización 08:10:45 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
14,57 ^AUD	-2,80 %		+1,32 %	-8,94 %

14/03	Clinuvel Pharmaceuticals lanza un programa de recompra de acciones	MT
14/03	CLINUVEL PHARMACEUTICALS LIMITED : Morgans Financial cambia su recomendación a compra	ZM

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors	28/03
Clinuvel Pharmaceuticals Launches Share Buyback Program	14/03
Clinuvel Pharmaceuticals Limited announces an Equity Buyback for 1,500,000 shares, representing 2.99% of its issued share capital.	14/03
Clinuvel Pharmaceuticals Limited authorizes a Buyback Plan.	14/03
Biotech-Unternehmen CLINUVEL launcht Photomedizin-Stiftung bei Event von Lady Gaga	07/03
Malibu shines a light on CLINUVEL’s pioneering work in photomedicine	05/03
Clinuvel Reports Positive Results in SCENESSE Study	04/03
Clinuvel Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	21/02
Clinuvel Pharmaceuticals Limited Announces Change to Registered Office	07/12
Clinuvel Doses First Patient in Phase 3 Trial of Vitiligo Treatment	18/10/23
Clinuvel Pharmaceuticals Limited Announces Board Changes	29/09/23
Clinuvel Pharmaceuticals Teams Up With Vitiligo Experts to Assess Scenesse	13/09/23
Clinuvel Pharmaceuticals Limited Announces Dividend for the Full Year Ended June 30, 2023, Payable on September 20, 2023	29/08/23
Clinuvel Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023	29/08/23
Clinuvel Pharmaceuticals Secures Supply Contract for Porphyria Medication with the US Department of Veterans Affairs	26/07/23
Clinuvel Pharmaceuticals Secures Patents for Melanocortins for Treatment of Central Nervous System Disorders	14/07/23
Clinuvel Pharmaceuticals Treats First Patient in Phase Two Stroke Trial	20/03/23
Clinuvel Pharmaceuticals Limited Announces Technical Note - CUV803 Study and AIS	20/03/23
Clinuvel Pharmaceuticals Limited Announces First Stroke Patient Treated with PRENUMBRA Instant	19/03/23
Clinuvel Pharmaceuticals Limited Present DNA Repair Data At American Academy of Dermatology Meeting	16/03/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Clinuvel Pharmaceuticals Limited

Acciones

CUV

AU000000CUV3

Otros idiomas

Filtros